Therapeutic Targets for Neurodevelopmental Disorders Emerging from Animal Models with Perinatal Immune Activation

Daisuke Ibi1,2, Kiyofumi Yamada3

  • 1Department of Chemical Pharmacology, Faculty of Pharmaceutical Sciences, Meijo University, 150 Yagotoyama, Tenpaku-ku, Nagoya 468-8503, Japan. ibid@meijo-u.ac.jp.

Insights

Perinatal viral infections increase psychiatric disorder risk. Researchers are exploring molecules involved in astrocyte-neuron and gut microbiome interactions as potential therapeutic targets for brain dysfunction.

Area of Science:

  • Neuroscience
  • Immunology
  • Psychiatry

Background:

  • Epidemiological studies link perinatal viral infections to increased psychiatric disorder risk.
  • Astrocyte-neuron and gut microbiome interactions are implicated in neurodevelopmental disorders following immune insults.
  • Maternal immune activation and polyriboinosinic polyribocytidylic acid models identify molecules involved in brain dysfunction.

Purpose of the Study:

  • To review the functions of candidate molecules in neurodevelopment and brain function.
  • To discuss the potential of these molecules as therapeutic targets for psychiatric disorders.

Main Methods:

  • Literature review of studies on perinatal infections, neurodevelopmental disorders, and candidate molecules.
  • Analysis of the role of astrocytes, neurons, and gut microbiomes in disease pathogenesis.
  • Examination of molecular mechanisms underlying brain dysfunction.

Main Results:

  • Several candidate molecules have been identified in neurodevelopmental disorder models.
  • These molecules play roles in neurodevelopment and overall brain function.
  • Astrocyte-neuron and gut microbiome interactions are crucial pathways.

Conclusions:

  • Understanding candidate molecules offers insights into psychiatric disorder development.
  • Targeting specific molecules may provide novel therapeutic strategies for psychiatric disorders.
  • Further research is needed to validate therapeutic potential.

Related Concept Videos